Phase II trial of poly-ICLC for glioblastoma
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2017
At a glance
- Drugs Poly ICLC (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 26 Jan 2017 Status changed from completed to discontinued after results of the EORTC phase-3 study defined the SOC for newly diagnosed GMB pts as RT plus concomitant and adjuvant TMZ .
- 09 May 2008 Status changed from in progress to completed, from clinicaltrials.gov record.
- 19 Sep 2005 New trial record.